Dr. Christopher J. Kane talks about the use of magnetic resonance imaging (MRI) in screening for prostate cancer. He goes on to discuss arguments for and against the possibility of using MRI before first prostate biopsy. (Click image to see video.)
Dr. Kane served on the program committee of the 2018 Genitourinary Cancers Symposium in San Francisco, February 8-10. (Video by
"Because of urology’s expansion and quality and because of the independence of the specialty nationally, I am pleased to announce that the division has been granted department status. The new Department of Urology in the School of Medicine will be led by an interim chair,
Christopher J. Kane, MD."
Dr. David Brenner, Vice Chancellor, UC San Diego Health Sciences and Dean of the School of Medicine
Read the full VC Message
Christopher J. Kane, MD, Professor and Joseph D. Schmidt, MD Presidential Chair in Urology, discusses challenges facing genetic testing for patients with prostate cancer.
According to Dr. Kane, "The technology often outstrips the ethics and the clinical precision of what we do with the data." Although physicians can acquire a great deal of genetic data, they are still unsure of how to apply that data clinically.
See the video here.